The present invention relates to humanized antibodies and binding proteins thereof, capable of binding to {HEAD ~ T cells} exhibiting {TAIL ~ particular variable beta chains}, and particularly those subpopulations expressing human V beta 5.2 and 5.3, and V beta 8.1 
exhibiting
The present invention relates to humanized antibodies and binding proteins thereof , capable of binding to { HEAD ~ T cells } exhibiting { TAIL ~ particular variable beta chains } , and particularly those subpopulations expressing human V beta 5.2 and 5.3 , and V beta 8.1
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH